Respirology Search
Respirology Respirology
pneumonia%20-%20community-acquired
PNEUMONIA - COMMUNITY-ACQUIRED
Community-Acquired Pneumonia (CAP) is an acute infection of the pulmonary parenchyma accompanied by symptoms of acute illness and abnormal chest findings.
It is a lower respiratory tract infection acquired in the community within 24 hours to <2 weeks or occurring ≤48 hours of hospital admission in patients who do not meet the criteria for healthcare-associated pneumonia.
It occurs at the highest rates in the very young and the very old.
Potentially life-threatening especially in older adults and those with comorbid disease.

Pneumonia - Community-Acquired Drug Information

Drug Information

Indication: Upper & lower resp tract infections including sinusitis, otitis media, epiglottitis, bacterial pneumonia, ...

Indication: Active immunisation of adults & childn ≥6 mth for prevention of influenza disease caused by 2 influenza...

Indication: Complicated skin & soft tissue infections, community-acquired pneumonia.

Indication: Oral: Lower resp tract infections including bronchitis & pneumonia; skin & soft tissue infections; acu...

Indication: Nosocomial & community-acquired pneumonia including concurrent bacteremia; complicated & uncomplicated...

Indication: Prevention of flu in persons ≥65 yr; adults & childn w/ chronic pulmonary & CV disorders, chronic m...

Indication: Immunisation against pneumococcal disease caused by those pneumococcal types included in the vaccine. Immunoco...

Synflorix
Haemophilus influenzae + pneumococcal polysacchari...

Indication: Active immunisation of infants & childn from 6 wk-5 yr against disease caused by S pneumoniae serotypes 1,...

Indication: Resp; GUT, ophth, skin & soft tissue, biliary tract, GI & ENT infections. Cholecystitis & cholangi...

Indication: Upper & lower resp tract infections, GUT, skin & soft tissue infections, gonorrhoea, acute uncomplicat...

2  /  26
2  /  26
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Ivermectin improves survival in COVID-19 patients with severe pulmonary involvement
21 Nov 2020
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
COVID-19: Are we close to a cure?
Elvira Manzano, 12 May 2020
After months of work disruption, profound worrying, social distancing, and isolation, SARS-CoV-2* still rages on, unyielding to human interventions.
Hexavalent, pneumococcal vaccine update included in national immunisation schedule
Rachel Soon, 05 Dec 2020

The Malaysian National Immunisation Programme (NIP) will now include a hexavalent combination DTaP-IPV-HiB-HepB vaccine and a pneumococcal vaccine.
Searches for unproven COVID-19 therapies spike after high-profile endorsements
Roshini Claire Anthony, 18 Jun 2020

Endorsement of unproven COVID-19 treatments by high-profile public figures led to a drastic increase in the search and purchase of said treatments in the US, according to a research letter published in JAMA.